ImmuPharma plc (LON:IMM – Get Free Report)’s share price crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 1.90 ($0.02) and traded as low as GBX 1.65 ($0.02). ImmuPharma shares last traded at GBX 1.68 ($0.02), with a volume of 198,040 shares trading hands.
ImmuPharma Stock Performance
The business has a 50 day moving average of GBX 1.74 and a two-hundred day moving average of GBX 1.89. The firm has a market capitalization of £7.01 million, a price-to-earnings ratio of -168.25 and a beta of 1.53.
About ImmuPharma
ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.
See Also
- Five stocks we like better than ImmuPharma
- Top Stocks Investing in 5G Technology
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- How to Calculate Options Profits
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
